The prevention of infective endocarditis in childhood in the Czech Republic, a current approach

Czech version

Authors: Klásková Eva ¹; Janoušek Jan ²
Authors‘ workplace: Dětské kardiocentrum, 2. lékařská fakulta, Univerzita Karlova a Fakultní nemocnice v Motole, Praha ²
Published in: Čes-slov Pediat 2024; 79 (1): 23-29.
Category: Prevention in pediatrics
doi: https://doi.org/10.55095/CSPediatrie2024/003

Overview

Prevention of infective endocarditis is an integral part of the management of paediatric patients with cardiovascular disease in the Czech Republic. The experience resulting from the restrictions on prophylactic antibiotic administration prior to high-risk procedures, which have been introduced worldwide, suggests that pediatric population may benefit from the antibiotic prophylaxis. In addition, it is essential to follow general preventive measures, especially the prevention of dental caries, and to educate the patient and parents about them.

Sources

1. Momtazmanesh S, Saeedi Moghaddam S, Malakan Rad E, et al. Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019. Eur J Prev Cardiol 2022; 29(8): 1287–1297.

2. Vicent L, Luna R, Martínez-Sellés. Pediatric infective endocarditis: a literature review. J Clin Med 2022; 11(11): 3217.

3. Hostaša J, Chaloupecký V, Škovránek J, et al. Chirurgická léčba infekční endokarditidy u dětí a mladistvých. Cor Vasa 2005; 46(11): 417–421.

4. Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Circulation 2022; 105: 2115–2126.

5. Cahill TJ, Jewell PD, Denne L, et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: A UK prospective study. Am Heart J 2019; 215: 70–77.

6. Jortveit J, Klcovansky J, Eskeda L, et al. Endocariditis in children and adolescents with congenital heart defects: a Norwegian nationwide register-based cohort study. Arch Dis Child 2018; 103: 670–674.

7. Marom D, Levy I, Gutwein O. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Inf Dis J 2011; 30: 585–588.

8. Carceller A, Lebel MH, Larose G, et al. New trends in pediatric endocarditis. An Pediatr 2005; 63: 396–402.

9. Gupta S, Sakhuja A, McGrath E, et al. Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Cong Heart Dis 2017; 12: 196–201.

10. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44(39): 3948–4042.

11. Halavaara M, Huotari K, Antilla V-J, et al. Healthcare-associated infective endocarditis: source of infection and burden of previous healthcare exposure. Antimicrob Steward Healthc Epidemiol 2023; 3: e152.

12. Thornhill MH, Crum A, Campbell R, et al. Temporal association between invasive procedures and infective endocarditis. Heart 2023; 109: 223–231.

13. AlSuliman FS, Alajlan SA, Algonaid OA, et al. Knowledge, attitude, and perception of oral health among parents of children at risk of infective endocarditis: a cross-sectional study. Cureus 2023: 15: e44855.

14. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116(15): 1736–1754.

15. National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis. 2008. (NICE clinical guideline No. 64). Dostupné na: www.nice.org.uk/CG064

16. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30(19): 2369–2413.

17. Habib G, Lancellotti P, Antunes MJ, et al. The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015; 36(44): 3036–3037.

18. Garg P, Ko DT, Bray Jenkyn KM, et al. Infective endocarditis hospitalizations and antibiotic prophylaxis rates before and after the 2007 American Heart Association Guideline Revision. Circulation 2019; 140(3): 170–180.

19. Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet 2015; 385(9974): 1219–1228.

20. Bates KE, Hall M, Shah SS, et al. Trends in infective endocarditis hospitalisations at United States children‘s hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Cardiol Young 2017; 27(4): 686–690.

21. Pasquali SK, He X, Mohamad Z, et al. Trends in endocarditis hospitalizations at US children‘s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J 2012; 163(5): 894–899.

22. Baddour LM, Janszky I, Thornhill MH, et al. Nondental invasive procedures and risk of infective endocarditis: time for a revisit: a science advisory from the American Heart Association. Circulation 2023; 10.1161/CIR.0000000000001180.

23. Chaloupecký V, Bartáková H, Nyč O. Diagnostika, léčba a prevence infekční endokarditidy u dětí doporučené Pracovní skupinou dětské kardiologie při České kardiologické a Pediatrické společnosti ČLS JEP. Čes-slov Pediat 2006; 61: 386–394.

24. Klásková E, Janousek J, Urbanová Z, et al. Dětská kardiologie do kapsy. Praha: Maxdorf 2021: 179–191.